These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33181666)

  • 1. Effect of FAT1 gene expression on the prognosis of medulloblastoma in children: A protocol for systematic review and meta-analysis.
    Yu J; Gao H; Su Z; Yue F; Tian X
    Medicine (Baltimore); 2020 Nov; 99(46):e23020. PubMed ID: 33181666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mirna-21 on survival prognosis in patients with pancreatic cancer: A protocol for systematic review and meta-analysis.
    Zhang W; Chen J; He G; Xu W; He G
    Medicine (Baltimore); 2020 Aug; 99(35):e22045. PubMed ID: 32871962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenotypic detection of circulating tumor cells marked by epithelial-mesenchymal transformation on the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
    Ge B; Wang Y; Lei S; Zhang J
    Medicine (Baltimore); 2020 Oct; 99(44):e22960. PubMed ID: 33126365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between long non-coding RNA TUG1 and prognosis of patients with gastric carcinoma: A protocol for systematic review and meta-analysis.
    Xia W; Zhang Q; Li Q; Liang X
    Medicine (Baltimore); 2020 Dec; 99(49):e23522. PubMed ID: 33285765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between long non-coding RNA and prognosis of patients with coronary heart disease after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Wang F; Cai X; Jiao P; Liu Y; Yuan B; Zhang P; Liu H; Ma L
    Medicine (Baltimore); 2020 Dec; 99(51):e23525. PubMed ID: 33371075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of FAT1 is associated with overall survival in children with medulloblastoma.
    Yu J; Li H
    Tumori; 2017 Jan; 103(1):44-52. PubMed ID: 27834469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
    Zhang W; Wei L; Luo R; Liu H; Chen J
    Medicine (Baltimore); 2020 Aug; 99(33):e21483. PubMed ID: 32871993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients.
    Chen K; Huang B; Yan S; Xu S; Li K; Zhang K; Wang Q; Zhuang Z; Wei L; Zhang Y; Liu M; Lian H; Zhong C
    Aging (Albany NY); 2020 Nov; 12(21):21481-21503. PubMed ID: 33159021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.
    Fu J; Yu Q; Xiao J; Li S
    Medicine (Baltimore); 2021 Apr; 100(17):e25596. PubMed ID: 33907110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTGF expression is indicative of better survival rates in patients with medulloblastoma.
    Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG
    Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
    Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
    Ding Y; Wu W; Ma Z; Shao X; Zhang M; Wang Z
    Medicine (Baltimore); 2021 Jun; 100(22):e25964. PubMed ID: 34087839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
    Chen Z; Xiao Z; Zeng S; Yan Z
    Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
    J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers.
    Clifford SC; O'Toole K; Ellison DW
    Cell Cycle; 2009 Mar; 8(5):787. PubMed ID: 19221477
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of microRNA-203 as a biomarker for the prognosis of esophageal cancer: A protocol for systematic review and meta-analysis.
    Wang S; Yu P; Meng Z; Feng L
    Medicine (Baltimore); 2020 Dec; 99(50):e23599. PubMed ID: 33327325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
    Zhao X; Song T; He Z; Tang L; Zhu Y
    Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
    Liu L; Zhang X; Li C; Qu Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26923. PubMed ID: 34397935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
    Ren Z; Li C; Gan Y; Liu X; Liang F
    Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.